Fujian Cosunter Pharmaceutical Co Ltd
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzh… Read more
Fujian Cosunter Pharmaceutical Co Ltd (300436) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.055x
Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has a cash flow conversion efficiency ratio of -0.055x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.74 Million) by net assets (CN¥468.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Fujian Cosunter Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Fujian Cosunter Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Russel Metals Inc
PINK:RUSMF
|
0.066x |
|
TriCo Bancshares
NASDAQ:TCBK
|
0.034x |
|
Montea Comm. VA
OTCGREY:MONSF
|
0.008x |
|
Select Energy Services Inc
NYSE:WTTR
|
0.077x |
|
Central Retail Corporation Public Company Limited
BK:CRC
|
0.105x |
|
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS
|
-0.050x |
|
Deliveroo Holdings PLC
PINK:DROOF
|
0.203x |
|
Visual China Group Co Ltd
SHE:000681
|
0.012x |
Annual Cash Flow Conversion Efficiency for Fujian Cosunter Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥396.78 Million | CN¥20.71 Million | 0.052x | +117.02% |
| 2023-12-31 | CN¥569.24 Million | CN¥-174.60 Million | -0.307x | -144.91% |
| 2022-12-31 | CN¥955.62 Million | CN¥-119.68 Million | -0.125x | -640.11% |
| 2021-12-31 | CN¥1.05 Billion | CN¥-17.76 Million | -0.017x | -163.14% |
| 2020-12-31 | CN¥581.99 Million | CN¥15.60 Million | 0.027x | -54.60% |
| 2019-12-31 | CN¥575.73 Million | CN¥33.99 Million | 0.059x | +203.26% |
| 2018-12-31 | CN¥562.19 Million | CN¥10.94 Million | 0.019x | -84.96% |
| 2017-12-31 | CN¥552.05 Million | CN¥71.47 Million | 0.129x | -3.16% |
| 2016-12-31 | CN¥552.36 Million | CN¥73.84 Million | 0.134x | -37.82% |
| 2015-12-31 | CN¥519.20 Million | CN¥111.63 Million | 0.215x | -68.49% |
| 2014-12-31 | CN¥156.87 Million | CN¥107.04 Million | 0.682x | +47.49% |
| 2013-12-31 | CN¥143.10 Million | CN¥66.20 Million | 0.463x | +19.69% |
| 2012-12-31 | CN¥108.59 Million | CN¥41.97 Million | 0.387x | -52.42% |
| 2011-12-31 | CN¥65.43 Million | CN¥53.15 Million | 0.812x | -- |